Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             52 results found
no title author magazine year volume issue page(s) type
1 Agreement Between the JCDCG, Revised NCEP-ATPIII, and IDF Definitions of Metabolic Syndrome in a Northwestern Chinese Population Sun, Fei
2018
9 4 p. 1457-1468
article
2 Agreement Between the JCDCG, Revised NCEP-ATPIII, and IDF Definitions of Metabolic Syndrome in a Northwestern Chinese Population Sun, Fei

9 4 p. 1457-1468
article
3 A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss Pereira, Maria J.
2018
9 4 p. 1511-1532
article
4 A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss Pereira, Maria J.

9 4 p. 1511-1532
article
5 Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons Balijepalli, Chakrapani
2018
9 4 p. 1491-1500
article
6 Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons Balijepalli, Chakrapani

9 4 p. 1491-1500
article
7 Cerebral Biochemical Effect of Pregabalin in Patients with Painful Diabetic Neuropathy: A Randomized Controlled Trial Jaeger, Mats De
2018
9 4 p. 1591-1604
article
8 Cerebral Biochemical Effect of Pregabalin in Patients with Painful Diabetic Neuropathy: A Randomized Controlled Trial De Jaeger, Mats

9 4 p. 1591-1604
article
9 Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea Han, Eugene
2018
9 4 p. 1689-1701
article
10 Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea Han, Eugene

9 4 p. 1689-1701
article
11 Characterization of the Open-Label Lead-In Period of Two Randomized Controlled Phase 3 Trials Evaluating Dapagliflozin, Saxagliptin, and Metformin in Type 2 Diabetes Mathieu, Chantal
2018
9 4 p. 1703-1711
article
12 Characterization of the Open-Label Lead-In Period of Two Randomized Controlled Phase 3 Trials Evaluating Dapagliflozin, Saxagliptin, and Metformin in Type 2 Diabetes Mathieu, Chantal

9 4 p. 1703-1711
article
13 Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study Fadini, Gian Paolo
2018
9 4 p. 1477-1490
article
14 Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study Fadini, Gian Paolo

9 4 p. 1477-1490
article
15 Contribution of BHG and PPHG to Overall Hyperglycemia in T2DM Patients Treated with LM25 and LM50: Post Hoc Analysis of a Randomized Crossover Trial Li, Wei
2018
9 4 p. 1605-1614
article
16 Contribution of BHG and PPHG to Overall Hyperglycemia in T2DM Patients Treated with LM25 and LM50: Post Hoc Analysis of a Randomized Crossover Trial Li, Wei

9 4 p. 1605-1614
article
17 Correction to: Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study Neeland, Ian J.
2018
9 4 p. 1721
article
18 Correction to: Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study Neeland, Ian J.

9 4 p. 1721
article
19 Correction to: Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ) Ishii, Hitoshi
2018
9 4 p. 1719
article
20 Correction to: Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ) Ishii, Hitoshi

9 4 p. 1719
article
21 Diabetes Fatigue Syndrome Kalra, Sanjay
2018
9 4 p. 1421-1429
article
22 Diabetes Fatigue Syndrome Kalra, Sanjay

9 4 p. 1421-1429
article
23 Efficacy and Safety of Sitagliptin in Hispanic/Latino Patients with Type 2 Diabetes: A Pooled Analysis from Ten Randomized, Placebo-Controlled Phase 3 Clinical Trials Raji, Annaswamy
2018
9 4 p. 1581-1589
article
24 Efficacy and Safety of Sitagliptin in Hispanic/Latino Patients with Type 2 Diabetes: A Pooled Analysis from Ten Randomized, Placebo-Controlled Phase 3 Clinical Trials Raji, Annaswamy

9 4 p. 1581-1589
article
25 Glycemic Control in Hospitalized Patients with Diabetes Receiving Corticosteroids Using a Neutral Protamine Hagedorn Insulin Protocol: A Randomized Clinical Trial Khowaja, Ameer
2018
9 4 p. 1647-1655
article
26 Glycemic Control in Hospitalized Patients with Diabetes Receiving Corticosteroids Using a Neutral Protamine Hagedorn Insulin Protocol: A Randomized Clinical Trial Khowaja, Ameer

9 4 p. 1647-1655
article
27 Handling Insulin-Related Emotions Kalra, Sanjay
2018
9 4 p. 1415-1419
article
28 Handling Insulin-Related Emotions Kalra, Sanjay

9 4 p. 1415-1419
article
29 Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study Ishihara, Hisamitsu
2018
9 4 p. 1549-1567
article
30 Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study Ishihara, Hisamitsu

9 4 p. 1549-1567
article
31 Long-Term Effect of the Color Record Method in Self-Monitoring of Blood Glucose on Metabolic Parameters in Type 2 Diabetes: A 2-Year Follow-up of the Color IMPACT Study Nishimura, Akiko
2018
9 4 p. 1501-1510
article
32 Long-Term Effect of the Color Record Method in Self-Monitoring of Blood Glucose on Metabolic Parameters in Type 2 Diabetes: A 2-Year Follow-up of the Color IMPACT Study Nishimura, Akiko

9 4 p. 1501-1510
article
33 Meta-Analysis of Sulfonylurea Therapy on Long-Term Risk of Mortality and Cardiovascular Events Compared to Other Oral Glucose-Lowering Treatments Powell, W. Ryan
2018
9 4 p. 1431-1440
article
34 Meta-Analysis of Sulfonylurea Therapy on Long-Term Risk of Mortality and Cardiovascular Events Compared to Other Oral Glucose-Lowering Treatments Powell, W. Ryan

9 4 p. 1431-1440
article
35 No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects Demmel, Valentin
2018
9 4 p. 1441-1456
article
36 No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects Demmel, Valentin

9 4 p. 1441-1456
article
37 Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis Carlsson Petri, Kristin Cecilie
2018
9 4 p. 1533-1547
article
38 Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis Carlsson Petri, Kristin Cecilie

9 4 p. 1533-1547
article
39 Similar Intrapatient Blood Glucose Variability with LY2963016 and LantusĀ® Insulin Glargine in Patients with Type 1 (T1D) or Type 2 Diabetes, Including a Japanese T1D Subpopulation Nishiyama, Hiroshi
2018
9 4 p. 1469-1476
article
40 Similar Intrapatient Blood Glucose Variability with LY2963016 and LantusĀ® Insulin Glargine in Patients with Type 1 (T1D) or Type 2 Diabetes, Including a Japanese T1D Subpopulation Nishiyama, Hiroshi

9 4 p. 1469-1476
article
41 Successful Management of Poorly Controlled Type 2 Diabetes with Multidisciplinary Neurobehavioral Rehabilitation: A Case Report and Review Deng, Zhihui
2018
9 4 p. 1713-1718
article
42 Successful Management of Poorly Controlled Type 2 Diabetes with Multidisciplinary Neurobehavioral Rehabilitation: A Case Report and Review Deng, Zhihui

9 4 p. 1713-1718
article
43 Switching From Pre-mixed Insulin to Regimens with Insulin Glargine in Type 2 Diabetes: A Prospective, Observational Study of Data From Adriatic Countries Petrovski, Goran
2018
9 4 p. 1657-1668
article
44 Switching From Pre-mixed Insulin to Regimens with Insulin Glargine in Type 2 Diabetes: A Prospective, Observational Study of Data From Adriatic Countries Petrovski, Goran

9 4 p. 1657-1668
article
45 The Associations between Paraoxonase 1 L55M/Q192R Genetic Polymorphisms and the Susceptibilities of Diabetic Macroangiopathy and Diabetic Microangiopathy: A Meta-Analysis Wu, Chenfang
2018
9 4 p. 1669-1688
article
46 The Associations between Paraoxonase 1 L55M/Q192R Genetic Polymorphisms and the Susceptibilities of Diabetic Macroangiopathy and Diabetic Microangiopathy: A Meta-Analysis Wu, Chenfang

9 4 p. 1669-1688
article
47 There is a Close Association Between the Recovery of Liver Injury and Glycemic Control after SGLT2 Inhibitor Treatment in Japanese Subjects with Type 2 Diabetes: A Retrospective Clinical Study Kinoshita, Tomoe
2018
9 4 p. 1569-1580
article
48 There is a Close Association Between the Recovery of Liver Injury and Glycemic Control after SGLT2 Inhibitor Treatment in Japanese Subjects with Type 2 Diabetes: A Retrospective Clinical Study Kinoshita, Tomoe

9 4 p. 1569-1580
article
49 Turkish Insulin Injection Techniques Study: Complications of Injecting Insulin Among Turkish Patients with Diabetes, Education They Received, and the Role of Health Care Professional as Assessed by Survey Questionnaire Dagdelen, Selcuk
2018
9 4 p. 1615-1628
article
50 Turkish Insulin Injection Techniques Study: Complications of Injecting Insulin Among Turkish Patients with Diabetes, Education They Received, and the Role of Health Care Professional as Assessed by Survey Questionnaire Dagdelen, Selcuk

9 4 p. 1615-1628
article
51 Turkish Insulin Injection Technique Study: Population Characteristics of Turkish Patients with Diabetes Who Inject Insulin and Details of Their Injection Practices as Assessed by Survey Questionnaire Dagdelen, Selcuk
2018
9 4 p. 1629-1645
article
52 Turkish Insulin Injection Technique Study: Population Characteristics of Turkish Patients with Diabetes Who Inject Insulin and Details of Their Injection Practices as Assessed by Survey Questionnaire Dagdelen, Selcuk

9 4 p. 1629-1645
article
                             52 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands